Survey
LUMRYZ LAUNCH PERFORMANCE & OUTLOOK SURVEY
Ticker(s): AVDL, JAZZSLEEP MEDICINE DOCTORS WHO TREAT NARCOLEPSY AND PRESCRIBE OXYBATE DRUGS -- ideally 1/3 of the survey participants will be HIGH VOLUME (HAVE OVER 15 PATIENTS ON OXYBATE THERAPY), 1/3 will be MEDIUM VOLUME (HAVE 7-15 PATIENTS ON OXYBATE THERAPY), and 1/3 will be LOW VOLUME (HAVE <7 PATIENTS ON OXYBATE THERAPY).
- How many NARCOLEPSY PATIENTS are under your care?
- How many NARCOLEPSY PATIENTS do you CURRENTLY have on OXYBATE THERAPY (XYREM, XYWAV, OR LUMRYZ)?
- Of the NARCOLEPSY PATIENTS you CURRENTLY have on OXYBATE THERAPY, how many do you specifically have on:
- XYWAV
- Branded XYREM
- Generic XYREM
- LUMRYZ
- How many NEW OXYBATE STARTS did you have OVER THE PAST YEAR?
- Factoring in the number of NEW OXYBATE STARTS that you had over the PAST YEAR and THE ADDITIONAL STARTS YOU MIGHT HAVE FROM PEOPLE WHO PREVIOUSLY TRIED OR WERE RECOMMENDED TO TRY OXYBATE BUT DIDN’T BECAUSE OF THE INCONVENIENCE OF 2X NIGHTLY DOSING, HOW MANY NEW OXYBATE STARTS DO YOU EXPECT TO HAVE OVER THE NEXT YEAR?
- Factoring in YOUR CURRENT POPULATION OF NARCOLEPSY PATIENTS ON OXYBATE, the natural flow of new patients and patient discontinuation, and the potential increased willingness to try oxybate therapy given that a 1x nightly version is available, HOW MANY PATIENTS DO YOU EXPECT TO HAVE ON OXYBATE THERAPY IN 3 YEARS?
- How many XYREM/XYWAV PATIENTS HAVE YOU SEEN SINCE LUMRYZ WAS LAUNCHED ON JUNE 1ST?
- What % of THOSE PATIENTS DID YOU PRESENT OR DISCUSS THE LUMRYZ OPTION WITH?
- What % of THE PATIENTS THAT YOU PRESENTED OR DISCUSSED THE LUMRYZ OPTION WITH CHOOSE TO SWITCH TO LUMRYZ?
- What is the main reason patients who switch chose to switch to lumryz?
- What is the main reason patients who didn’t switch to lumryz didn’t switch?
- What % of the patients
who want to switch to LUMRYZ from EXISTING OXYBATE THERAPY do you think
you can GET APPROVED to switch by insurance RIGHT NOW?
- Since JUNE 1st, how many (if any) patients Did you prescribe LUMRYZ TO that WERE PREVIOUSLY ON OXYBATE THERAPY BUT DISCONTINUED?
- Factoring in the frequency of patient visits and the expected pacing of coverage by insurance of LUMRYZ, how many patients that ARE CURRENTLY ON XYREM OR XYWAV would you expect TO SWITCH TO LUMRYZ by the following points in time:
- September 30, 2023?
- December 31, 2023?
- June 30, 2024?
- What % of your NEW OXYBATE STARTS OVER THE NEXT YEAR do you expect to put on the following drugs:
- LUMRYZ?
- XYWAV?
- Branded XYREM?
- Generic XYREM?
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
